Theranos

About us Our mission is to make actionable information accessible to everyone at the time it matters. By making actionable information accessible to everyone in the world at the time it matters most, we are working to facilitate the early detection and prevention of disease, and empower people everywhere to live their best possible lives. Theranos is headquartered in Palo Alto, CA. https://theranos.com

Kezar Life Sciences

We are a clinical-stage biotechnology company combining courage, conviction and cutting-edge science to develop breakthrough treatments for immune-mediated and oncologic disorders, with the hope of helping patients overcome their disease and live a better life. We are pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function and inhibit multiple drivers of disease via a single target. In modulating the function of profound intracellular regulators, our medicines have the potential for significant clinical impact in the most difficult-to-treat diseases. We believe the wide-ranging impact of our therapeutic platforms can be applied across a vast array of indications to create victories for patients most in need.

Genomelink

Genomelink is a DNA App Store where people upload and store DNA data to access more insights, products, and health research. We are on missions to; - Build a world #1 consumer application platform - Help advancement of genomics and health science - Bring back DNA data ownership to your hand

lucence

Lucence is a precision oncology company committed to bringing clarity to cancer care. Lucence makes ultrasensitive non-invasive liquid biopsy tests to provide doctors and their patients life-changing information to enable earlier detection and effective treatment. Headquartered in Palo Alto and Singapore, Lucence supplies personalized cancer care services through twin CLIA-licensed laboratories in the United States and Singapore. For more information, visit www.lucence.com.

Drug Hunter

Drug Hunter™ is an essential resource for the community of R&D innovators turning molecules into medicines. Drug Hunter distills the science behind emerging drugs and technologies into an easy-to-read and simple-to-search reference. The company was founded in 2018 out of a scientist’s frustration with existing ways to learn about new drugs and the science of pharma. Now, thousands of R&D leaders from every major pharma and biotech company in the world choose to invest their time in Drug Hunter over crawling through the literature alone. Our products and subscription services including drughunter.com, the Drug Hunter Newsletter, Drug Hunter Events, and Drug Hunter Premium subscription make the science behind drug discovery easier to find, helping innovators keep up with best practices, find ideas, and identify partners with a fraction of the cost of traditional practices. Drug Hunter products and services are used by researchers at every major pharma and biotech in the world, leading universities like Harvard, and top VC and equity research firms. We help drug hunters learn about technical products and services in partnership with relevant, technically-sophisticated sponsors. Our PhD team helps create relevant content for expert CROs, CDMOs, software, and equipment providers that are helpful to scientists. Our PhDs also consult for leading investment firms and market research divisions to understand critical issues in small molecule drug discovery. Reach out at drughunter.com/contact to find out how we can help you.